Replies to post #174766 on Biotech Values

[dav1234]

130 tickers up more than 100% in a year.. http://finviz.com/screener.ashx?v=211&f=sec_healthcare,ta_perf_52w100o&ft=3

[jq1234]

NVO had a rather significant setback though, delayed entry to US market by ultra long acting basal insulin Tresiba.